The impact of COMT polymorphisms on cognition in Bipolar Disorder: A review

A. Pigoni, M. Lazzaretti, G. M. Mandolini, G. Delvecchio, A. C. Altamura, J. C. Soares, P. Brambilla

Research output: Contribution to journalArticle

Abstract

Background: Cognitive deficits represent a core feature of Bipolar Disorder. The dopamine system is considered fundamental for cognitive functions relying on prefrontal cortex, such as attention and executive functions. A genetic regulation of prefrontal dopamine has been described and the catechol-O-methyltransferase (COMT) has been extensively studied in relation to numerous psychiatric phenotypes, especially because of the involvement of its polymorphisms in the regulation of cognitive functions. Specifically, the Val158Met polymorphism greatly alters COMT function and cognitive performance in both psychiatric disorders and healthy controls. However, only few studies assessed the association between COMT polymorphisms and cognitive functions in bipolar disorder (BD) subjects and this association might help in the comprehension of cognitive alterations in BD. Methods: In this context, the present review summarizes results from genetic studies that investigated COMT genetic modulation on cognitive performance in patients affected by BD. Results: Overall the results confirmed that (a) COMT Val158Met polymorphism is associated with altered cognitive functions in BD patients, especially in the domains of memory, executive functions and emotion detection; and (b) COMT genotype may interact with both mood episodes and pharmacologic treatments in determining the cognitive profile of these subjects. Limitations: Few genetic studies exploring COMT genetic effect on cognition in BD. Conclusions: These findings seem to indicate a role of COMT polymorphisms in regulating cognitive functioning in patients with BD. The genetically determined dopaminergic tone may be further affected by mood episodes and pharmacological treatments.

LanguageEnglish
Pages545-551
JournalJournal of Affective Disorders
Volume243
DOIs
Publication statusPublished - 2019

Fingerprint

Catechol O-Methyltransferase
Bipolar Disorder
Cognition
Executive Function
Psychiatry
Dopamine
Prefrontal Cortex
Emotions
Genotype
Pharmacology
Phenotype
Therapeutics

Keywords

  • Bipolar Disorder
  • Cognition
  • COMT
  • Genes
  • SNPs

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

The impact of COMT polymorphisms on cognition in Bipolar Disorder : A review. / Pigoni, A.; Lazzaretti, M.; Mandolini, G. M.; Delvecchio, G.; Altamura, A. C.; Soares, J. C.; Brambilla, P.

In: Journal of Affective Disorders, Vol. 243, 2019, p. 545-551.

Research output: Contribution to journalArticle

Pigoni, A. ; Lazzaretti, M. ; Mandolini, G. M. ; Delvecchio, G. ; Altamura, A. C. ; Soares, J. C. ; Brambilla, P. / The impact of COMT polymorphisms on cognition in Bipolar Disorder : A review. In: Journal of Affective Disorders. 2019 ; Vol. 243. pp. 545-551.
@article{d1e012eec9924766810405502aad7b1d,
title = "The impact of COMT polymorphisms on cognition in Bipolar Disorder: A review",
abstract = "Background: Cognitive deficits represent a core feature of Bipolar Disorder. The dopamine system is considered fundamental for cognitive functions relying on prefrontal cortex, such as attention and executive functions. A genetic regulation of prefrontal dopamine has been described and the catechol-O-methyltransferase (COMT) has been extensively studied in relation to numerous psychiatric phenotypes, especially because of the involvement of its polymorphisms in the regulation of cognitive functions. Specifically, the Val158Met polymorphism greatly alters COMT function and cognitive performance in both psychiatric disorders and healthy controls. However, only few studies assessed the association between COMT polymorphisms and cognitive functions in bipolar disorder (BD) subjects and this association might help in the comprehension of cognitive alterations in BD. Methods: In this context, the present review summarizes results from genetic studies that investigated COMT genetic modulation on cognitive performance in patients affected by BD. Results: Overall the results confirmed that (a) COMT Val158Met polymorphism is associated with altered cognitive functions in BD patients, especially in the domains of memory, executive functions and emotion detection; and (b) COMT genotype may interact with both mood episodes and pharmacologic treatments in determining the cognitive profile of these subjects. Limitations: Few genetic studies exploring COMT genetic effect on cognition in BD. Conclusions: These findings seem to indicate a role of COMT polymorphisms in regulating cognitive functioning in patients with BD. The genetically determined dopaminergic tone may be further affected by mood episodes and pharmacological treatments.",
keywords = "Bipolar Disorder, Cognition, COMT, Genes, SNPs",
author = "A. Pigoni and M. Lazzaretti and Mandolini, {G. M.} and G. Delvecchio and Altamura, {A. C.} and Soares, {J. C.} and P. Brambilla",
year = "2019",
doi = "10.1016/j.jad.2018.08.009",
language = "English",
volume = "243",
pages = "545--551",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

TY - JOUR

T1 - The impact of COMT polymorphisms on cognition in Bipolar Disorder

T2 - Journal of Affective Disorders

AU - Pigoni, A.

AU - Lazzaretti, M.

AU - Mandolini, G. M.

AU - Delvecchio, G.

AU - Altamura, A. C.

AU - Soares, J. C.

AU - Brambilla, P.

PY - 2019

Y1 - 2019

N2 - Background: Cognitive deficits represent a core feature of Bipolar Disorder. The dopamine system is considered fundamental for cognitive functions relying on prefrontal cortex, such as attention and executive functions. A genetic regulation of prefrontal dopamine has been described and the catechol-O-methyltransferase (COMT) has been extensively studied in relation to numerous psychiatric phenotypes, especially because of the involvement of its polymorphisms in the regulation of cognitive functions. Specifically, the Val158Met polymorphism greatly alters COMT function and cognitive performance in both psychiatric disorders and healthy controls. However, only few studies assessed the association between COMT polymorphisms and cognitive functions in bipolar disorder (BD) subjects and this association might help in the comprehension of cognitive alterations in BD. Methods: In this context, the present review summarizes results from genetic studies that investigated COMT genetic modulation on cognitive performance in patients affected by BD. Results: Overall the results confirmed that (a) COMT Val158Met polymorphism is associated with altered cognitive functions in BD patients, especially in the domains of memory, executive functions and emotion detection; and (b) COMT genotype may interact with both mood episodes and pharmacologic treatments in determining the cognitive profile of these subjects. Limitations: Few genetic studies exploring COMT genetic effect on cognition in BD. Conclusions: These findings seem to indicate a role of COMT polymorphisms in regulating cognitive functioning in patients with BD. The genetically determined dopaminergic tone may be further affected by mood episodes and pharmacological treatments.

AB - Background: Cognitive deficits represent a core feature of Bipolar Disorder. The dopamine system is considered fundamental for cognitive functions relying on prefrontal cortex, such as attention and executive functions. A genetic regulation of prefrontal dopamine has been described and the catechol-O-methyltransferase (COMT) has been extensively studied in relation to numerous psychiatric phenotypes, especially because of the involvement of its polymorphisms in the regulation of cognitive functions. Specifically, the Val158Met polymorphism greatly alters COMT function and cognitive performance in both psychiatric disorders and healthy controls. However, only few studies assessed the association between COMT polymorphisms and cognitive functions in bipolar disorder (BD) subjects and this association might help in the comprehension of cognitive alterations in BD. Methods: In this context, the present review summarizes results from genetic studies that investigated COMT genetic modulation on cognitive performance in patients affected by BD. Results: Overall the results confirmed that (a) COMT Val158Met polymorphism is associated with altered cognitive functions in BD patients, especially in the domains of memory, executive functions and emotion detection; and (b) COMT genotype may interact with both mood episodes and pharmacologic treatments in determining the cognitive profile of these subjects. Limitations: Few genetic studies exploring COMT genetic effect on cognition in BD. Conclusions: These findings seem to indicate a role of COMT polymorphisms in regulating cognitive functioning in patients with BD. The genetically determined dopaminergic tone may be further affected by mood episodes and pharmacological treatments.

KW - Bipolar Disorder

KW - Cognition

KW - COMT

KW - Genes

KW - SNPs

UR - http://www.scopus.com/inward/record.url?scp=85052066008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052066008&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2018.08.009

DO - 10.1016/j.jad.2018.08.009

M3 - Article

VL - 243

SP - 545

EP - 551

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -